Nintedanib in restrictive chronic lung allograft dysfunction after lung transplantation

被引：19
|
作者：
Suhling, Hendrik [1 ]
Bollmann, Benjamin [1 ]
Gottlieb, Jens [1 ]
机构：
[1] Hannover Med Sch, Dept Resp Med, Hannover, Germany
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2016年 / 35卷 / 07期
关键词：
D O I：
10.1016/j.healun.2016.01.1220
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：939 / 940
页数：2
相关论文
共 50 条
  • [1] Restrictive allograft dysfunction after lung transplantation: is there a place for nintedanib?-a case report
    Pluchart, Helene
    Chanoine, Sebastien
    Briault, Amandine
    Claustre, Johanna
    Bedouch, Pierrick
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (03) : 408 - 411
  • [2] Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation
    Verleden, Stijn E.
    Ruttens, David
    Vandermeulen, Elly
    Belton, Hannelore
    Dubbeldam, Adriana
    De Wever, Walter
    Dupont, Lieven J.
    Van Raemdonck, Dirk E.
    Vanaudenaerde, Bart M.
    Verleden, Geert M.
    Benden, Christian
    Vos, Robin
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (09): : 1078 - 1084
  • [3] Restrictive Lung Disease as a Manifestation of Chronic Allograft Dysfunction Following Lung Transplantation
    Paraskeva, M.
    Bailey, M.
    Snell, G. I.
    Westall, G. P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S53 - S53
  • [4] Montelukast in chronic lung allograft dysfunction after lung transplantation
    Vos, Robin
    Vanden Eynde, Ruben
    Ruttens, David
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Dupont, Lieven J.
    Yserbyt, Jonas
    Verbeken, Eric K.
    Neyrinck, Arne P.
    Van Raemdonck, Dirk E.
    Verleden, Geert M.
    Godinas, Laurent
    Van Herck, Anke
    Vanstapel, Arno
    Sacreas, Annelore
    Kaes, Janne
    Heigl, Tobias
    Ordies, Sofie
    Schaevers, Veronique
    De Leyn, Paul
    Coosemans, Willy
    Nafteux, Philippe
    Decaluwe, Herbert
    Van Veer, Hans
    Depypere, Lieven
    Frick, Anna E.
    Ceulemans, Laurens J.
    Weynand, Birgit
    Emonds, Marie-Paule
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05): : 516 - 527
  • [5] National experience with Nintedanib for restrictive allograft syndrome following lung transplantation
    Schultz, H. H.
    Bendstrup, E.
    Jensen, K.
    Davidsen, J. R.
    Lund, T. K.
    Perch, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Chronic lung allograft dysfunction after lung transplantation: The moving target
    Sato M.
    General Thoracic and Cardiovascular Surgery, 2013, 61 (2) : 67 - 78
  • [7] Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
    Sato, Masaaki
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [8] Primary Graft Dysfunction Increases the Risk of Baseline Lung Allograft Dysfunction but Not Chronic Lung Allograft Dysfunction after Lung Transplantation
    Li, D.
    Hirji, A.
    Weinkauf, J. G.
    Lien, D. C.
    Kapasi, A. M.
    Halloran, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S327 - S327
  • [9] Restrictive allograft syndrome after lung transplantation
    Klouda, Timothy
    Vargas, Sara O.
    Midyat, Levent
    PEDIATRIC TRANSPLANTATION, 2021, 25 (03)
  • [10] Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
    Nobuyuki Yoshiyasu
    Masaaki Sato
    World Journal of Transplantation, 2020, (05) : 104 - 116
12345